{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:07:15Z","timestamp":1792433235426,"version":"4.5.0"},"reference-count":88,"publisher":"Centers for Disease Control MMWR Office","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6404a1","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T19:45:12Z","timestamp":1449171912000},"page":"1-22","source":"Crossref","is-referenced-by-count":381,"title":["Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident"],"prefix":"10.15585","volume":"64","author":[{"name":"Prepared by","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Bower","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hendricks","sequence":"additional","affiliation":[{"name":"Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Pillai","sequence":"additional","affiliation":[{"name":"Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Guarnizo","sequence":"additional","affiliation":[{"name":"Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Meaney-Delman","sequence":"additional","affiliation":[{"name":"Office of the Director, National Center for Emerging and Zoonotic Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2015,12,4]]},"reference":[{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7205\/MILMED.171.7.589","article-title":"Development of a risk-priority score for category A bioterrorism agents as an aid for public health policy.","volume":"171","author":"MacIntyre","year":"2006","journal-title":"Mil Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.mam.2009.07.002","article-title":"Preparedness for an anthrax attack.","volume":"30","author":"Franz","year":"2009","journal-title":"Mol Aspects Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R4","unstructured":"World Health Organization. Health aspects of chemical and biological weapons: a report of a WHO group of consultants. Geneva, Switzerland: World Health Organization; 1970."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid0302.970201","article-title":"The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?","volume":"3","author":"Kaufmann","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979.","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.","volume":"90","author":"Abramova","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.287.7.863","article-title":"Fatal inhalational anthrax in a 94-year-old Connecticut woman.","volume":"287","author":"Barakat","year":"2002","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R10","unstructured":"CDC. Considerations for anthrax vaccine adsorbed (AVA) post-exposure prioritization final. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http:\/\/emergency.cdc.gov\/bioterrorism\/pdf\/AVA-Post-Event-Prioritization-Guidance.pdf."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/path.1700730219","article-title":"The pathogenesis of anthrax following the administration of spores by the respiratory route.","volume":"73","author":"Ross","year":"1957","journal-title":"J Pathol Bacteriol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0882-4010(89)90108-3","article-title":"Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.","volume":"7","author":"Welkos","year":"1989","journal-title":"Microb Pathog"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/JB.79.4.594-600.1960","article-title":"Comparison of graded and quantal virulence tests for Bacillus Anthracis Spores.","volume":"79","author":"Fernelius","year":"1960","journal-title":"J Bacteriol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0966-842X(99)01507-3","article-title":"Understanding Bacillus anthracis pathogenesis.","volume":"7","author":"Hanna","year":"1999","journal-title":"Trends Microbiol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005.","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JB.95.3.907-918.1968","article-title":"Purification and properties of in vitro-produced anthrax toxin components.","volume":"95","author":"Fish","year":"1968","journal-title":"J Bacteriol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin.","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R18","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mam.2009.07.003","article-title":"Cellular and systemic effects of anthrax lethal toxin and edema toxin.","volume":"30","author":"Moayeri","year":"2009","journal-title":"Mol Aspects Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R20","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.","volume":"261","author":"Friedlander","year":"1986","journal-title":"J Biol Chem"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R21","unstructured":"National Health Service, National Services Scotland, Health Protection Scotland. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team. Galsgow, Scotland, UK: National Services Scotland; 2013. Available at http:\/\/www.documents.hps.scot.nhs.uk\/giz\/anthrax-outbreak\/anthrax-outbreak-report-2011-12.pdf."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00009","article-title":"Accuracy of screening for inhalational anthrax after a bioterrorist attack.","volume":"139","author":"Hupert","year":"2003","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(04)16769-X","article-title":"Clinical predictors of bioterrorism-related inhalational anthrax.","volume":"364","author":"Kyriacou","year":"2004","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/346035","article-title":"Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses.","volume":"36","author":"Kuehnert","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/512372","article-title":"A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3201\/eid2002.130245","article-title":"Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, Minnesota, USA.","volume":"20","author":"Sprenkle","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3201\/eid0807.020062","article-title":"Anthrax of the gastrointestinal tract.","volume":"8","author":"Sirisanthana","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/archinte.163.20.2527","article-title":"Gastrointestinal anthrax: review of the literature.","volume":"163","author":"Beatty","year":"2003","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s15010-003-3169-3","article-title":"Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey.","volume":"31","author":"Demirdag","year":"2003","journal-title":"Infection"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1378\/chest.53.6.773","article-title":"Corticosteroid in treatment of malignant edema of chest wall and neck (anthrax).","volume":"53","author":"Doust","year":"1968","journal-title":"Dis Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R31","first-page":"176","article-title":"A major epidemic of anthrax in Zimbabwe: the experience at the Beatrice Road Infectious Diseases Hospital, Harare.","volume":"31","author":"Davies","year":"1985","journal-title":"Cent Afr J Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/WNL.59.3.327","article-title":"Anthrax meningoencephalitis.","volume":"59","author":"Lanska","year":"2002","journal-title":"Neurology"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R33","unstructured":"Institute of Medicine. Finding what works in health care: standards for systematic reviews. Eden J, Levit L, Berg A, Morton S, eds: The National Academies Press; 2011."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R34","doi-asserted-by":"crossref","unstructured":"Hendricks KA, Wright ME, Shadomy SV, Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20. Available at .10.3201\/eid2002.130687","DOI":"10.3201\/eid2002.130687"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R35","article-title":"Antitoxin treatment for inhalation anthrax: a systematic review.","author":"Huang","journal-title":"Health Security."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R36","article-title":"antimicrobial treatment for systemic anthrax: analysis of cases from 1945\u20132014 identified through systematic literature review.","author":"Pillai","journal-title":"Health Security."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1378\/chest.12-0447","article-title":"Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis.","volume":"143","author":"Mercaldi","year":"2013","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R38","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1345\/aph.1Q642","article-title":"Clozapine-induced peripheral and pleural fluid eosinophilia.","volume":"46","author":"Patel","year":"2012","journal-title":"Ann Pharmacother"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R39","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1001\/jama.297.16.1810","article-title":"Does this patient with a pericardial effusion have cardiac tamponade?","volume":"297","author":"Roy","year":"2007","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(75)91571-8","article-title":"Effusions into body cavities in hypothyroidism.","volume":"1","author":"Sachdev","year":"1975","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R41","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00134-011-2317-y","article-title":"Lung ultrasound in critically ill patients: comparison with bedside chest radiography.","volume":"37","author":"Xirouchaki","year":"2011","journal-title":"Intensive Care Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1755-5922.2010.00151.x","article-title":"Treatment of pericardial disease.","volume":"29","author":"Azam","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R43","first-page":"283","article-title":"Ascites in cirrhosis: a review of management and complications.","volume":"65","author":"Kuiper","year":"2007","journal-title":"Neth J Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R44","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ca.22032","article-title":"Pericardiocentesis: a clinical anatomy review.","volume":"25","author":"Loukas","year":"2012","journal-title":"Clin Anat"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R45","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s10620-007-9805-5","article-title":"An evidence-based manual for abdominal paracentesis.","volume":"52","author":"McGibbon","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R46","doi-asserted-by":"crossref","unstructured":"Meaney-Delman D, Zotti ME, Creanga AA, Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg Infect Dis 2014;20. Available at .10.3201\/eid2002.130611","DOI":"10.3201\/eid2002.130611"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R47","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1542\/peds.2014-0563","article-title":"Pediatric anthrax clinical management.","volume":"133","author":"Bradley","year":"2014","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R48","unstructured":"Institute of Medicine. Crisis standards of care: a systems framework for catastrophic disaster response. Washington, DC: The National Academies Press; 2012."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R49","doi-asserted-by":"crossref","first-page":"e61S","DOI":"10.1378\/chest.14-0736","article-title":"Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Christian","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R50","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.14-0733","article-title":"Surge capacity principles: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Hick","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R51","doi-asserted-by":"crossref","first-page":"e75S","DOI":"10.1378\/chest.14-0737","article-title":"Special populations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Dries","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R52","doi-asserted-by":"crossref","first-page":"e87S","DOI":"10.1378\/chest.14-0738","article-title":"System-level planning, coordination, and communication: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Dichter","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R53","doi-asserted-by":"crossref","first-page":"e145S","DOI":"10.1378\/chest.14-0742","article-title":"Ethical considerations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Biddison","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3200\/HTPS.85.3.16-25","article-title":"Ethical triage and scarce resource allocation during public health emergencies: tenets and procedures.","volume":"85","author":"Kuschner","year":"2007","journal-title":"Hosp Top"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R55","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00006454-199312000-00020","article-title":"Bacillus anthracis as a cause of bacterial meningitis.","volume":"12","author":"Tabatabaie","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R56","doi-asserted-by":"crossref","unstructured":"Berger T, Kassirer M, Aran AA. Injectional anthrax: new presentation of an old disease. Euro Surveill. 2014;19(32):pii=20877. Available at .DOI: 10.2807\/1560-7917.ES2014.19.32.20877","DOI":"10.2807\/1560-7917.ES2014.19.32.20877"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R57","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.annemergmed.2005.11.035","article-title":"Anthrax: a systematic review of atypical presentations.","volume":"48","author":"Holty","year":"2006","journal-title":"Ann Emerg Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R58","first-page":"327","article-title":"Haines B. anthrax.","volume":"9","author":"Lincoln","year":"1964","journal-title":"Adv Vet Sci"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R60","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.","volume":"62\u20138","author":"Goldstein","year":"2005"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R61","first-page":"22","article-title":"Federal legal preparedness tools for facilitating medical countermeasure use during public health emergencies.","volume":"41","author":"Courtney","year":"2013","journal-title":"Med Ethics (Burlingt, Mass)"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R62","unstructured":"Federal Drug Administration. Raxibacumab: treatment of inhalational anthrax. Silver Spring, MD: Federal Drug Administration; 2012."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R63","first-page":"461","article-title":"Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.","volume":"60","author":"Yee","year":"2010","journal-title":"Comp Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R64","doi-asserted-by":"crossref","first-page":"19076.","DOI":"10.2807\/ese.13.51.19076-en","article-title":"Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008.","volume":"13","author":"Anaraki","year":"2008","journal-title":"Euro Surveill"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMcpc1003887","article-title":"Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.","volume":"363","author":"Klempner","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R66","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1378\/chest.07-2693","article-title":"Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26\u201327, 2007, Chicago, IL.","volume":"133","author":"Devereaux","year":"2008","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R67","unstructured":"Department of Veterans Affairs. Meeting the challenge of pandemic influenza: ethical guidance for leaders and health care professionals in the Veterans Health Administration. Washington, DC: Department of Veterans Affairs; 2010."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/dmp.2010.41","article-title":"MSOFA: An important step forward, but are we spending too much time on the SOFA?","volume":"4","author":"Rubinson","year":"2010","journal-title":"Disaster Med Public Health Prep"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1365-2044.2009.06135.x","article-title":"An assessment of the validity of SOFA score based triage in H1N1 critically ill patients during an influenza pandemic.","volume":"64","author":"Khan","year":"2009","journal-title":"Anaesthesia"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R70","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3201\/eid2009.131481","article-title":"Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010.","volume":"20","author":"Booth","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R71","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1378\/chest.14-0732","article-title":"Task Force for Mass Critical Care; Task Force for Mass Critical Care. Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","volume":"146","author":"Christian","year":"2014","journal-title":"Chest"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R72","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00006454-199312000-00020","article-title":"Bacillus anthracis as a cause of bacterial meningitis.","volume":"12","author":"Tabatabaie","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R73","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1471-2334-13-408","article-title":"Two anthrax cases with soft tissue infection, severe oedema and sepsis in Danish heroin users.","volume":"13","author":"Russell","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S0963180103124164","article-title":"Ethical resource distribution after biological, chemical, or radiological terrorism.","volume":"12","author":"Iserson","year":"2003","journal-title":"Camb Q Healthc Ethics"},{"issue":"136","key":"key-10.15585\/mmwr.rr6404a1-201512031434-R75","first-page":"1","article-title":"Pregnancy rates for U.S. women continue to drop.","author":"Curtin","year":"2013","journal-title":"NCHS Data Brief"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R76","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection.","volume":"370","author":"Kourtis","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R77","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/AOG.0b013e3182a5fdfd","article-title":"Prophylaxis and treatment of anthrax in pregnant women.","volume":"122","author":"Meaney-Delman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R78","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0b013e318270ec08","article-title":"Anthrax cases in pregnant and postpartum women: a systematic review.","volume":"120","author":"Meaney-Delman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/bsp.2006.0011","article-title":"Bioterrorism-related inhalational anthrax: can extrapolated adult guidelines be applied to a pediatric population?","volume":"5","author":"Place","year":"2007","journal-title":"Biosecur Bioterror"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R80","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archpedi.161.9.896","article-title":"Inhalational, gastrointestinal, and cutaneous anthrax in children: a systematic review of cases: 1900 to 2005.","volume":"161","author":"Bravata","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R81","first-page":"3432","article-title":"Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.","volume":"77","author":"Boyer","year":"2009","journal-title":"Biosecur Bioterror"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R82","unstructured":"Barr JR, Boyer AE, Hoffmaster AR, Detection and quantification of anthrax toxins by mass spectrometry: application to clinical anthrax [Abstract 77-Mo:160]. International Conference onBacillus anthracis, B cereusandB thuringiensis; August 7\u201311, 2011; Bruges, Belgium."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R83","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1021\/ac701741s","article-title":"Detection and quantification of anthrax lethal factor in serum by mass spectrometry.","volume":"79","author":"Boyer","year":"2007","journal-title":"Anal Chem"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R84","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jir543","article-title":"Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.","volume":"204","author":"Boyer","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R85","unstructured":"Boyer AE, Lins RC, Gallegos M, Kinetics of anthrax toxins, lethal factor and edema factor during inhalation anthrax in rhesus macaques [Abstract 77-Mo:160]. International Conference onBacillus anthracis, B cereusandB thuringiensis; August 7\u201311, 2011; Bruges, Belgium."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R86","unstructured":"Boyer AE, Gallegos-Candela M, Lins RC, Relationship between circulating lethal factor, edema factor and toxin complexes during clinical and experimental anthrax [Abstract S8:5:44]. International Conference onBacillus anthracis, B cereusandB thuringiensis; September 1\u20135, 2013, Victoria, British Columbia, Canada."},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R87","doi-asserted-by":"crossref","first-page":"e106393","DOI":"10.1371\/journal.pone.0106393","article-title":"Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.","volume":"9","author":"Kammanadiminti","year":"2014","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.rr6404a1-201512031434-R88","unstructured":"US Department of Health and Human Services. Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) implementation plan. Washington, DC: US Department of Health and Human Services; 2012."}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T05:09:12Z","timestamp":1653714552000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6404a1.htm"}},"subtitle":["CDC Recommendations"],"short-title":[],"issued":{"date-parts":[[2015,12,4]]},"references-count":88,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12,4]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6404a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,4]]}}}